Skip to main content

Table 1 Baseline socio-demographic and clinical characteristics of the HAART patients (n = 792)

From: Factors affecting first month adherence due to antiretroviral therapy among HIV-positive adults at Felege Hiwot Teaching and Specialized Hospital, north-western Ethiopia; a prospective study

Variables

Characteristics

Median (IQR)

n (%)

Weight

Base line weight in K.G.

62 (58–70)

 

Base line CD4

Baseline CD cell count

134 (113–180)

 

Age

Age in years

36 (28–48)

 

1st month CD4 count change

First month CD4 cell count change

15.9 (12–26)

 

Sex

Male

 

391(49.4%)

Female

 

401(50.6%)

Level of education.

No educ.

 

160 (20.2%)

Primary

 

205 (25.9%)

Secondary

 

273(34.5%)

Tertiary

 

154 (19.4%)

Residence area

Urban

 

468 (59.1%)

Rural

 

324 (40.1%)

Marital status

Living with partner

 

355 (44.8%)

Living without Partner

 

437(55.2%)

Level of income

Low income (<  500 ETB per month)

 

355 (44.8%)

Middle income (5001–999 ETB per month)

 

346 (43.7%)

High income (≥1000ETB per month)

 

91(11.5%)

WHO stages

Stage I

 

101(12.8%)

Stage II

 

258 (32.6%)

Stage III

 

199 (25.1%)

Stage IV

 

234 (29.5%)

Disclosure level of disease to families

Yes

 

575 (72.6%)

No

 

217 (27.4%)

Owner of cell phone/memory aids

Yes

 

400 (50.5%)

No

 

392 (49.5%)

First month dose adherence

Yes

 

392 (49.5%)

No

 

400 (50.5%)

First month food adherent

Yes

 

385 (48.6%)

No

 

407 (51.4%)

First month time adherent

Yes

 

350 (44.2%)

No

 

442 (55.8%)

First month adherence to HAART

Yes

 

540 (68.18%)

No

 

252 (31.82%)

Social support

Yes

 

500 (63%)

No

 

292 (37%)